ACPURISINTENSIVE SPOT TREATMENT (MEDIWAY KOREA CO., LTD.)
Welcome to the PulseAid listing for the ACPURIS drug offered from MEDIWAY KOREA CO., LTD.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | MEDIWAY KOREA CO., LTD. |
| NON-PROPRIETARY NAME: | SALICYLIC ACID |
| SUBSTANCE NAME: | SALICYLIC ACID |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | CUTANEOUS |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
| START MARKETING DATE: | 2010-09-01 |
| END MARKETING DATE: | 0000-00-00 |
ACPURIS INTENSIVE SPOT TREATMENT HUMAN OTC DRUG Details:
| Item Description | ACPURIS INTENSIVE SPOT TREATMENT from MEDIWAY KOREA CO., LTD. |
| LABELER NAME: | MEDIWAY KOREA CO., LTD. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | 0.3(mL/15mL) |
| START MARKETING DATE: | 2010-09-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52797-020_a02ebf87-4daa-4c13-a3cf-0d826af3758f |
| PRODUCT NDC: | 52797-020 |
| APPLICATION NUMBER: | part333D |